Rockwell Medical (RMTI) Cash from Operations (2010 - 2026)
Rockwell Medical (RMTI) posted Cash from Operations of 200000.0 for Q1 2026, down 108.89% on a QoQ basis from 2250000.0 in Q4 2025, and up 94.26% year-over-year from 102952.47 in Q1 2025.
Rockwell Medical (RMTI) Cash from Operations (2010 - 2026) Analysis & Trends
Rockwell Medical's Cash from Operations history runs 17 years deep, the most recent figure standing at 200000.0 for Q1 2026.
- Quarterly Cash from Operations rose 94.26% year-over-year to 200000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2587000.0 (down 16.41% YoY) and the FY2025 annual result came in at 700000.0, down 116.66% from the prior year.
- Cash from Operations was 200000.0 for Q1 2026 at Rockwell Medical, down from 2250000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 4275000.0 in Q3 2024 and bottomed at 9811000.0 in Q1 2022.
- A 5-year average of 1355235.29 and a median of 1102000.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations slumped 240.56% — and 2024, when it soared 2111.63%.
- Rockwell Medical's Cash from Operations stood at 112000.0 in 2022, then soared by 61.61% to 43000.0 in 2023, then surged by 2111.63% to 865000.0 in 2024, then surged by 160.12% to 2250000.0 in 2025, then slumped by 108.89% to 200000.0 in 2026.
- Business Quant data shows RMTI's Cash from Operations at 200000.0 in Q1 2026, 2250000.0 in Q4 2025, and 1350000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | -200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -200,000.00 |
| Mar 31, 2026 | -200,000.00 |
| Dec 31, 2025 | 2.25 Mn |
| Dec 31, 2025 | 2.25 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Mar 31, 2025 | -3.49 Mn |
| Mar 31, 2025 | -3.49 Mn |
| Dec 31, 2024 | 865,000.00 |
| Dec 31, 2024 | 865,000.00 |
| Sep 30, 2024 | 4.28 Mn |
| Sep 30, 2024 | 4.28 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Mar 31, 2024 | -2.38 Mn |
| Mar 31, 2024 | -2.38 Mn |
| Dec 31, 2023 | -43,000.00 |
| Dec 31, 2023 | -43,000.00 |